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ARRHYTHMOGENIC SUBSTRATES ABLATED AT THE AORTOMITRAL 
CONTINUITY - POTENTIAL INVOLVEMENT OF THE CONDUCTION SYSTEM 
Jo Jo Hai, Anwar A Chahal, Faisal F Syed, Christopher V DeSimone, Peter A Brady, Yong-mei 
Cha, Paul A Friedman, Christopher J McLeod, Siva Mulpuru, Thomas M Munger and Samuel J 
Asirvatham 
BACKGROUND: Although successful ablation of ventricular arrhythmias (VA) at the 
aortomitral continuity (AMC) has been described, arrhythmogenic substrates at this fibrous 
region remain undefined. We sought to characterize the electrophysiological properties of 
arrhythmogenic substrates involved in these arrhythmias. 
METHOD: We reviewed 528 patients who underwent ablation of VA at our institution. We 
evaluated clinical and electrophysiological characteristics of VA successfully ablated at the AMC, 
as confirmed by fluoroscopy and intracardiac echocardiography. 
RESULTS: Of the 21 patients (mean age 53.2±13.4 years, 52% male) identified, 16 (76.2%) 
presented with symptomatic premature ventricular complexes (PVC), 2 (9.5%) with heart failure, 
2 (9.5%) with sustained ventricular tachycardia and 1 (4.8%) with PVC-triggered ventricular 
fibrillation. Mechanism of VA was triggered automaticity in 18 (85.7%) and indeterminate in 3 
(14.3%) of them. Pre-potentials (P, Figure) were found at sites of successful ablation in 13 
(61.9%) patients, with a mean P to local ventricular electrogram (VEGM) interval of 
65.7±34.1ms. Compared to those without P, patients with P had higher PVC burden (26.1±10.9% 
vs 14.9±10.1%, p=0.03), lower pacemap score (8.7±1.6 vs 11.4±0.8/12, p=0.001), shorter VEGM 
to QRS interval (9.0±28.5 vs 33.1±8.8ms, p=0.03) and a trend towards shorter VH interval 
(32.1±38.6 vs 76.3±11.1ms, p=0.056) during VA. There was a strong correlation between VH 
interval and QRS duration during VA (r=0.99, p<0.001). 
CONCLUSION: We present evidence that remnant conduction tissue, evidenced by pre-potential 
and short VH interval that correlated with QRS duration during arrhythmia, represents 
arrhythmogenic substrates in 61.9% of VA arising from the AMC. Clinicians should not only rely 
on the earliest VEGM or ideal pacemaps but specifically look for pre-potentials when targeting 
VA in this location. 
 
